Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training

被引:64
作者
Eto, Y
Yonekura, K
Sonoda, M
Arai, N
Sata, M
Sugiura, S
Takenaka, K
Gualberto, A
Hixon, ML
Wagner, MW
Aoyagi, T
机构
[1] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA
关键词
exercise; hypertrophy; signal transduction;
D O I
10.1161/01.CIR.101.18.2134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Calcineurin may play a pivotal role in the signaling of cardiac hypertrophy; since this hypothesis was first put forward, controversial reports have been published using various experimental models. This study was designed to compare the physiological left ventricular hyper-trophy (LVH) induced by voluntary exercise with LVH induced by aortic constriction and to determine whether calcineurin participates in the signaling of exercise-induced LVH. Methods and Results-Wistar rats were assigned to 1 of the following 5 groups: 10 weeks of voluntary exercise (EX), a sedentary regimen, a 1-week (AC1) or l-week (AC4) ascending aortic constriction period, or a sham operation, EX rats ran 2.4+/-0.7 km/day voluntarily in specially manufactured cages; this was associated with an increase of LV diastolic dimension and stroke volume. Myocardial calcineurin activity markedly increased in EX rats (46.4+/-8.3 versus 18.4+/-0.5 pmol.min(-1).mg(-1) in sedentary rats; P<0.001) and in AC1 rats (44.9+/-6.7 versus 22.1+/-3.7 pmol.min(-1). ms(-1) in sham-operated rats; P<0.001), but not in AC4 rats (29.0+3.3 pmol.min(-1).mg(-1)). Treatment with cyclosporin A completely inhibited the development of LVH in EX rats, but it only partially attenuated the development of LVH in AC4 rats, Conclusions-Calcineurin was activated in exercise-induced physiological LVI-I and in the developing phase of LVH (ACI), but not in decompensated pressure-overload hypertrophy (AC4). Cyclosporin therapy for the prevention of LVH may be harmful because it does not block the development of pathological hypertrophy but rather that of favorable adaptive hypertrophy.
引用
收藏
页码:2134 / 2137
页数:4
相关论文
共 15 条
[1]   The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts [J].
Aoyagi, T ;
Yonekura, K ;
Eto, Y ;
Matsumoto, A ;
Yokoyama, I ;
Sugiura, S ;
Momomura, S ;
Hirata, Y ;
Baker, DL ;
Periasamy, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (04) :919-926
[2]   LEFT-VENTRICULAR GEOMETRY, PATHOPHYSIOLOGY AND PROGNOSIS [J].
DEVEREUX, RB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (04) :885-887
[3]   Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin [J].
Ding, B ;
Price, RL ;
Borg, TK ;
Weinberg, EO ;
Halloran, PF ;
Lorell, BH .
CIRCULATION RESEARCH, 1999, 84 (06) :729-734
[4]   p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties [J].
Gualberto, A ;
Marquez, G ;
Carballo, M ;
Youngblood, GL ;
Hunt, SW ;
Baldwin, AS ;
Sobrino, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :7088-7093
[5]   Calcineurin and human heart failure [J].
Lim, HW ;
Molkentin, JD .
NATURE MEDICINE, 1999, 5 (03) :246-247
[6]   Calcineurin inhibitors and cardiac hypertrophy [J].
Luo, ZY ;
Shyu, KG ;
Gualberto, A ;
Walsh, K .
NATURE MEDICINE, 1998, 4 (10) :1092-1093
[7]   Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure [J].
Meguro, T ;
Hong, C ;
Asai, K ;
Takagi, G ;
McKinsey, TA ;
Olson, EN ;
Vatner, SF .
CIRCULATION RESEARCH, 1999, 84 (06) :735-740
[8]   A calcineurin-dependent transcriptional pathway for cardiac hypertrophy [J].
Molkentin, JD ;
Lu, JR ;
Antos, CL ;
Markham, B ;
Richardson, J ;
Robbins, J ;
Grant, SR ;
Olson, EN .
CELL, 1998, 93 (02) :215-228
[9]   CHRONIC EXERCISE ALTERS CONTRACTILITY AND MORPHOLOGY OF ISOLATED RAT CARDIAC MYOCYTES [J].
MOORE, RL ;
MUSCH, TI ;
YELAMARTY, RV ;
SCADUTO, RC ;
SEMANCHICK, AM ;
ELENSKY, M ;
CHEUNG, JY .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :C1180-C1189
[10]  
ROCCO MB, 1986, J AM COLL CARDIOL, V7, pA191